Skip to content

Astrana Health ASTH Acquisitions

Acquisitions at other companies

CVS Health logo
CVS HealthCVS
$5M-75.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$42.2M+525%
Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY
$4.2M-90.5%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$0-100%
Tenet Healthcare logo
Tenet HealthcareTHC
$121M+348%
Elevance Health logo
Elevance HealthELV
-$5M-25.0%

Other financials

Income statement

See full
Revenue$965.1M+55.6%
Gross profit$105.7M+48.2%
Operating income$28.5M+38.6%
Net income$14.4M+116%
EPS (diluted)$0.29+107%

Balance sheet

See full
Cash & equivalents$478.4M+85.0%
Total debt$1.1B+136%
Total equity$800.3M+7.4%
Total assets$2.4B+77.2%

Cash flow

See full
Operating cash flow$68.1M+309%
CapEx$4.0M+30.3%
Free cash flow$64.1M+372%

Valuation

See full
Market cap$2.1B-3.0%

Profitability

See full
Gross margin10.7%-1.3pp
Operating margin2.5%-1.1pp
Net margin0.9%
FCF margin4.6%

Returns & leverage

See full
Return on equity3.9%
Debt / equity1.3×+0.7×
Current ratio1.3×-0.4×

Where this comes from

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Astrana Health’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Astrana Health's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Astrana Health's acquisitions?
Astrana Health (ASTH) reported acquisitions of $51K in Q4 2025.
How has Astrana Health's acquisitions changed year-over-year?
Astrana Health's acquisitions decreased by 99.8% year-over-year, from $30.77M to $51K.
What is the long-term trend for Astrana Health's acquisitions?
Over 4 years (2021 to 2025), Astrana Health's acquisitions has grown at a 281.7% compound annual growth rate (CAGR), from $2.59M to $548.6M.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.